$ News

Novartis concludes Regulus Therapeutics acquisition

Novartis completes acquisition of Regulus Therapeutics

Regulus: Q1 Earnings Snapshot

Regulus Therapeutics Reports First Quarter 2025 Financial Results and Recent Updates

Regulus Therapeutics Enters into Agreement to be Acquired by Novartis AG

Promising Penny Stocks To Consider In April 2025

Should You Buy Regulus (RGLS) After Golden Cross?

Is Regulus Therapeutics Inc. (RGLS) the Best Rising Penny Stock to Buy According to Analysts?

Regulus Therapeutics to Present at the 2025 Oppenheimer Innovation on the Island Biotech Summit

Sector Update: Health Care Stocks Advance Late Afternoon

Top Midday Gainers

Regulus Therapeutics Announces Successful Completion of its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of Farabursen (RGLS8429) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Regulus Therapeutics (RGLS): One of the Best Short-Term Stocks to Buy Right Now

Is Regulus Therapeutics (NASDAQ:RGLS) In A Good Position To Invest In Growth?

Regulus: Q4 Earnings Snapshot

Regulus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Updates

Regulus Therapeutics to Present at the Leerink Partners 2025 Global Healthcare Conference

Regulus Therapeutics Inc. (RGLS): Among the Cheapest Stocks Insiders Are Buying Recently

Regulus Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Insiders Give Up US$8.7k As Regulus Therapeutics Stock Drops To US$1.00